More about DuPont de Nemours, Inc.
Regulatory Filings for DuPont de Nemours, Inc.
Fundamentals for DuPont de Nemours, Inc.
Debt, Deficits & Disaster: The Bond Market Crisis
Not Wall Street, But AI: The Real Force Democratizing Finance Across America
When Flooding Pays: A New Financial Bet
Breakfast for Life How Local Diners and Hardware Stores are Outsmarting Amazon
Fundamentals for DuPont de Nemours, Inc.
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Revenue projections:
DuPont de Nemours, Inc.'s revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.
Financial Ratios:
| currentRatio | 2.41900 |
|---|---|
| forwardPE | 17.94776 |
| debtToEquity | 24.48400 |
| earningsGrowth | 0.00000 |
| revenueGrowth | 0.00000 |
| grossMargins | 0.34501 |
| operatingMargins | 0.34687 |
| trailingEps | 0.21000 |
| forwardEps | 2.54405 |
With a current ratio of 2.419, DuPont de Nemours, Inc. has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that DuPont de Nemours, Inc. is in a strong position to meet its immediate financial obligations without difficulty.
DD's Forward PE is at a healthy level, meaning the stock price is aligned favorably with earnings. This suggests that the stock isn't overpriced, providing room for growth and making it an appealing option for investors looking to capitalize on potential future gains.
DD's low Debt-to-Equity ratio suggests the company is minimally leveraged, with limited reliance on debt to finance its operations. This reduced financial risk positions the company for greater stability and financial health, appealing to investors who value conservative financial management.
DuPont de Nemours, Inc.'s positive gross and operating margins indicate that the company is performing profitably. These margins reflect efficient cost control and revenue generation, signaling a strong financial foundation for continued success.
Price projections:
Price projections for DuPont de Nemours, Inc. have been revised downward over time, signaling decreasing optimism about the company's outlook. Analysts appear to be adjusting their expectations as concerns about future performance grow.
Insider Transactions:
DuPont de Nemours, Inc. stock was sold in 3 transactions, with market price at 34.86475626627604.The period under consideration saw no sell transactions.The trend of more buys compared to sells around DD's current price levels may signal investor optimism. This behavior suggests that the market is expecting a favorable outcome for the stock, leading to increased buying activity.
Recommendation changes over time:
Analysts have maintained a buy bias for DD, which could prompt investors to consider the stock as a viable investment. With this positive outlook, DD is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
Before They Can Walk, They're Invested: How Trump Accounts Are Transforming Financial Culture
The Appalachian Energy Reboot: Inside the Unexpected Nuclear Startup Boom
Theatrical Finance: Credit Unions Use Drama to Attract Youth